Document:

EXHIBIT 10.20

  

  
    Emergent BioSolutions Inc.

    

    

    Non-Qualified Stock Option Award Agreement – Irish Participant

    

    

    1.                  Grant
            of Option.

    This evidences the grant by Emergent BioSolutions Inc., a Delaware corporation (the “Company”), to an employee of the Company (the “Participant”),
        of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Stock Incentive Plan (the “Plan”), that number
        of shares (the “Shares”) of common stock, with a $0.001 par value per share, of the Company (“Common Stock”) set forth under the summary of  the grant in your account in the Company’s third-party electronic stock administrative platform (the “Grant Summary”) at the Grant Price identified on the Grant Summary.  Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on the Expiration Date identified on the Grant Summary.

    This option shall not be an incentive stock option as defined in Section 422 of the Internal Revenue
        Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”).  Except as otherwise indicated by the context, the term
        “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

    The grant of options under the Plan is made at the discretion of the Company and the Plan may be
        suspended or terminated by the Company at any time.

    2.                  Vesting
            Schedule.

    This non-qualified stock option shall vest in the aggregate in three equal annual installments on
        the day immediately prior to each anniversary of the grant date.  Specifically, this option shall vest in accordance with the future vesting schedule indicated on the detailed view of the option as viewed under your account in the Company’s
        third-party electronic stock administrative platform.

    The right of exercise shall be cumulative so that to the extent the option is not exercised in any
        period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Expiration Date or the termination of this option under Section 3 hereof
        or the Plan.

    3.                  Form
            of Exercise.  Each election to exercise this option shall be in accordance with the Company’s policies and procedures.

    The Participant may purchase less than the number of shares covered hereby, provided that no
        partial exercise of this option may be for any fractional share.

    (a)              Continuous
            Relationship with the Company Required.  Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the
        grant date, an employee, officer or director of, or consultant or advisor to, the Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”).

    (b)              Termination
            of Relationship with the Company.  If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (c) and (d) below, the right to exercise this option shall terminate 90 days after such
        cessation (but in no event after the Expiration Date), provided that
        this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation.  Notwithstanding the foregoing, if the Participant, prior to the Expiration Date, violates the
        non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon
        such violation.

    (c)              Exercise
            Period Upon Death or Disability.  If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Expiration Date while he or she is an Eligible Participant and the Company has not
        terminated such relationship for “cause” as specified in paragraph (d) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death
        by an authorized transferee), provided that this option shall be
        exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Expiration Date.

    (d)              Termination
            for Cause.  If, prior to the Expiration Date, the Participant’s employment or other relationship with the Company is terminated by the Company for Cause (as defined in the Plan), the right to exercise this option shall terminate
        immediately upon the effective date of such termination of employment or other relationship.

    4.                  Withholding.

    No Shares will be issued pursuant to the exercise of this option unless and until the Participant
        pays to the Company or the relevant subsidiaries, or makes provision satisfactory to the Company or the relevant subsidiaries for payment of, any relevant withholding taxes and social security required by law to be withheld in respect of this
        option.

    5.                  Nontransferability
            of Option.

    This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the
        Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, shall be exercisable only by the Participant; provided, however, that the gratuitous
        transfer of this Option by the Participant to or for the benefit of any immediate family member, domestic partner, family trust or other entity established for the benefit of the Participant and/or an immediate family member thereof if, with
        respect to such proposed transferee, the Company would be eligible to use a Registration Statement on Form S-8 for the registration of the sale of the Common Stock subject to such Option under the Securities Act of 1933, as amended; provided,
        further, that the Company shall not be required to recognize any such transfer until such time as the Participant and such authorized transferee shall, as a condition to such transfer, deliver to the Company a written instrument in form and
        substance satisfactory to the Company confirming that such transferee shall be bound by all of the terms and conditions of the Option; and, provided, further, that no option intended to be an incentive stock option shall be transferable unless the
        Board of Directors shall otherwise permit.

    6.                  No
            compensation for Loss

    Under no circumstances on ceasing to be in employment or service of the Company or a subsidiary,
        will the Participant be entitled to any compensation for any loss of any right or benefit or prospective right or benefit under the Plan which the Participant might otherwise have enjoyed whether such compensation is claimed by way of damages for
        wrongful dismissal or other breach of contract or by way of compensation for loss of office or otherwise howsoever.

    7.         Data
            Protection

    (a) The Participant expressly acknowledges that the Company’s processing of his personal data is necessary:

    i.  for the performance of
        this Irish Stock Option Award Agreement;

    ii.  for the legitimate
        interests of the Company (which includes all the interests noted in Section 7(b) (i)-(vi) below); and/or

    iii.  to comply with the
        Company’s legal obligations in Ireland and/or other EU member states in connection with: (a) the Participant’s employment; (b) any litigation, internal or regulatory investigation; or (c) as otherwise permitted by the Data Protection Act 1998 or by
        Regulation EU 2016/679 (the “GDPR”).

    

    

    (b) The Participant further acknowledges that the Company’s processing of his sensitive, or special categories of, personal data (which may
        include information relating to health, personal characteristics, criminal offences, allegations of criminal conduct and trade union membership) is necessary:

    
      	
              i. 

            	
              to carry out its or their obligations to the Participant in the fields of employment,
                  social security, and/or social protection;

            

    

    ii.  for the purposes of
        preventative or occupational medicine, or the assessment of working capacity;

    iii.  for statistical purposes
        and equal opportunities monitoring;

    iv.  to administer its
        pensions and benefits schemes;

    v.  in connection with the
        establishment, exercise or defence of legal claims; and/or

    vi.  for reasons of
        substantial public interest, as further described in the Company’s data protection policy.

    (c)     The processing may include disclosure of personal data and sensitive or special categories
        of personal data to third parties including benefit providers, prospective purchasers or service providers and governmental authorities.

    (d) A separate privacy notice has been provided to you in accordance with article 13 of the GDPR.

    (e) The Participant expressly acknowledges that the Company may transfer such data outside the European Economic Area (including, in particular,
        to offices in the United States) for such purposes and acknowledge that such countries may not have laws which adequately safeguard such data.        

    8. Provisions of the Plan.

    This option is subject to the provisions of the Plan, a copy of which is
        furnished to the Participant with this option.EXHIBIT 10.21

    

     

    

    Emergent BioSolutions Inc.

    

    

    Form of Restricted Stock Unit Award Agreement – Irish Participant

    

    

    1. Grant of RSUs.  In consideration of services rendered to the
        Company by the Participant, the Company has granted to the Participant, subject to the terms and conditions set forth herein and in the Company’s Stock Incentive Plan (the “Plan”), an award of Restricted Stock Units (the “RSUs”), representing the number of RSUs
        set forth under your account in the Company’s third-party electronic stock administrative platform.  The RSUs entitle the Participant to receive, upon and subject to the vesting of the RSUs (as described in Section 2 below), one share of common stock, $0.001 par value per share, of the Company (the “Common Stock”) for each RSU that vests.  The shares of Common Stock that are issuable upon vesting of the RSUs are referred to herein as the “Shares.”

    The grant of RSUs under the Plan is made at the discretion of the Company and the Plan may be suspended or
        terminated by the Company at any time.

    

    

    2. Vesting of RSUs and Issuance of Shares.

    (a) General.  Subject to the
        other provisions of this Section 2, the RSUs shall vest one-third per year over three years on the day immediately prior to the applicable anniversary of the grant date, in accordance with the future vesting schedule (the “Vesting Schedule”) set forth under your account in the Company’s third-party electronic stock administrative platform.  Subject to Section 4, as soon as
        administratively practicable after each vesting date shown in the Vesting Schedule (each a “Vesting Date”), the Company will issue to the
        Participant, in certificated or uncertificated form, such number of Shares as is equal to the number of RSUs that vested on such Vesting Date.  In no event shall the Shares be issued to the Participant later than 75 days after the Vesting Date.

    (b) Service Termination.
         Except as set forth in Section 2(c) below, upon the cessation of the Participant’s service with the Company as an employee, consultant or director of the Company for any reason, all unvested RSUs shall be automatically forfeited as of such
        cessation of service, subject to applicable law. For purposes of this RSU award, service with the Company shall include service as an employee or director of, or consultant to, the Company or to a parent or
        subsidiary of the Company, or any successor to the Company.

    (c) Change in Control Event. 
        Upon a Change in Control Event (as defined in the Plan), the RSUs shall be treated in the manner provided in Section 9(b)(iii)(B) of the Plan.

    3. Dividends. 
        At the time of the issuance of Shares to the Participant pursuant to Section 2, the Company shall also pay to the Participant an amount of cash equal to the aggregate amount of all dividends paid by the Company, between the grant date and the
        issuance of such Shares, with respect to the number of Shares so issued to the Participant.

    4. Withholding Taxes.   The Participant must satisfy all income
        and employment tax and social security withholding obligations associated with the grant, vesting and settlement of the RSUs before the Company will issue any Shares hereunder following a Vesting Date.  The withholding obligation may be satisfied
        by any method permitted under the Plan.

    5. Restrictions on Transfer.  Neither the RSUs, nor any interest
        therein (including the right to receive dividend payments in accordance with Section 3), may be transferred by the Participant except to the extent specifically permitted in Section 10(a) of the Plan.

    6. Provisions of the Plan.  This RSU award is subject to the
        provisions of the Plan. The Participant acknowledges receipt of the Plan, along with the Prospectus relating to the Plan.

    7. Data Protection.

    (a) The Participant expressly acknowledges that the Company’s processing of his personal data is necessary:

    (1) for the performance of this Irish RSU Award Agreement;

    (2) for the legitimate interests of the Company (which includes all the interests noted in Section 7(b) (1)-(6) below); and/or

    (3) to comply with the Company’s legal obligations in Ireland and/or other EU member states in connection with: (a) the Participant’s
        employment; (b) any litigation, internal or regulatory investigation; or (c) as otherwise permitted by the Data Protection Act 1998 or by Regulation EU 2016/679 (the “GDPR”).

    (b) The Participant further acknowledges that the Company’s processing of his sensitive, or special categories of, personal data (which
        may include information relating to health, personal characteristics, criminal offences, allegations of criminal conduct and trade union membership) is necessary:

    (1) to carry out its or their obligations to the Participant in the fields of employment, social security, and/or social protection;

    (2) for the purposes of preventative or occupational medicine, or the assessment of working capacity;

    (3) for statistical purposes and equal opportunities monitoring;

    (4) to administer its pensions and benefits schemes;

    (5) in connection with the establishment, exercise or defense of legal claims; and/or

    (6) for reasons of substantial public interest, as further described in the Company’s data protection policy.

    (c) The processing may include disclosure of personal data and sensitive or special categories of personal
        data to third parties including benefit providers, prospective purchasers or service providers and governmental authorities.

    (d) A separate privacy notice has been provided in accordance with article 13 of the GDPR.

    8. (e) The Participant expressly acknowledges that the Company may transfer such data outside the European Economic Area (including, in particular, to offices in the United States) for such purposes and
        acknowledge that such countries may not have laws which adequately safeguard such data.

    9. Section 409A.  This RSU award is intended to comply with or
        be exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and the guidance issued thereunder (“Section 409A”) and shall be interpreted and construed consistently therewith.  In no event shall either the Participant or the
        Company have the right to accelerate or defer delivery of the Shares to a date or event other than as set forth herein except to the extent specifically permitted or required by Section 409A.  In the event that the Participant is a “specified
        employee” within the meaning of Section 409A and the Shares are to be delivered in connection with the termination of the Participant’s employment, the delivery of the Shares and any dividends payable under Section 3 in connection with such
        delivery shall be delayed until the date that is six months and one day following the date of the Participant’s termination of employment if required to avoid the imposition of additional taxes under Section 409A.  Solely for purposes of
        determining when the Shares (and any dividends payable under Section 3) may be delivered in connection with the Participant’s termination of employment, such termination of employment must constitute a “separation from service” within the meaning
        of Section 409A.

    10. Miscellaneous.

    (a) No Rights to Service or Compensation
            for Loss.  The Participant acknowledges and agrees that the grant of the RSUs and their vesting pursuant to Section 2 do not constitute an express or implied promise of continued employment or service with the Company for the vesting
        period, or for any period. Under no circumstances on ceasing to be in employment or service of the Company or a subsidiary, will the Participant be entitled to any compensation for any loss of any right or benefit or prospective right or benefit
        under the Plan which the Participant might otherwise have enjoyed whether such compensation is claimed by way of damages for wrongful dismissal or other breach of contract or by way of compensation for loss of office or otherwise howsoever.

    (b) Entire Agreement.  These
        terms and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the subject matter of this RSU award; provided that any separate employment, consulting, or severance plan or
        agreement between the Company and the Participant that includes terms relating to the acceleration of vesting of equity awards shall not be superseded by these terms.

    (c) Governing Law.  This RSU
        award shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflict of law principles.

    (d) Interpretation.  The
        interpretation and construction of any terms or conditions of the Plan or this RSU award by the Compensation Committee shall be final and conclusive.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]